<DOC>
	<DOCNO>NCT00956891</DOCNO>
	<brief_summary>The study aim investigate short-term efficacy long-term prognosis liver failure patient cause hepatitis B single transplantation autologous marrow mesenchymal stem cell ( MMSCs ) . Liver failure inpatient cause hepatitis B recruit receive medical treatment , among patient underwent single transplantation autologous MMSCs patient match age , gender biochemical index [ alanine aminotransferase ( ALT ) , albumin ( ALB ) , total bilirubin ( TBIL ) , prothrombin time ( PT ) Model End-stage Liver Disease ( MELD ) ] control group . A total 120 ml bone marrow obtain patient , dilute separate . Then MMSCs suspension slowly transfuse liver proper hepatic artery interventional procedure . The level ALB , TBIL , PT MELD score patient translation group compare control group . In 3 ~ 48 month follow-up , difference long-term outcome incidence HCC ( hepatocellular carcinoma ) mortality two group compare .</brief_summary>
	<brief_title>Therapeutic Effects Liver Failure Patients Caused Chronic Hepatitis B After Autologous MSCs Transplantation</brief_title>
	<detailed_description>A total 527 patient chronic hepatitis B induce liver failure recruit May 2005 June 2009 department . The diagnosis chronic hepatitis B liver failure base previously describe criterion . All patient receive medical treatment ( reducibility glutathione , glycyrrhizin , ademetionine , polyene phosphatidylcholine , alprostadil , human serum albumin ) . Informed consent obtain study . Among patient , 53 receive transplantation autologous MMSCs . The day surgery serve first day observation . And 105 patient matched age , gender biochemical index ( ALT , ALB , TBIL , PT MELD ) serve control .</detailed_description>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Polyene phosphatidylcholine</mesh_term>
	<criteria>Liver failure HBV negative</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>short-term effect</keyword>
	<keyword>long-term follow-up</keyword>
	<keyword>liver failure patient</keyword>
	<keyword>autologous MSCs transplantation</keyword>
</DOC>